Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Tallant

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
ACS Chemical Biology|March 22, 2016
Structure of the Human Protein Kinase ZAK in Complex with VemurafenibSebastian Mathea, Kamal R Abdul Azeez, Eidarus Salah, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2015
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responsesAriane Hammitzsch, Cynthia Tallant, Oleg Fedorov, et al.
Nature Chemical Biology|May 10, 2016
Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talkSara Sdelci, Charles-Hugues Lardeau, Cynthia Tallant, et al.
Journal of Medicinal Chemistry|July 18, 2017
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of ProteinsNiall Igoe, Elliott D Bayle, Cynthia Tallant, et al.
Angewandte Chemie (International Ed. in English)|April 14, 2015
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorPeter G K Clark, Lucas C C Vieira, Cynthia Tallant, et al.
Journal of Medicinal Chemistry|January 10, 2017
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo StudiesNiall Igoe, Elliott D Bayle, Oleg Fedorov, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|June 28, 2016
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorPeter G K Clark, Lucas C C Vieira, Cynthia Tallant, et al.
ACS Chemical Biology|January 31, 2017
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye DiseaseJennifer Batson, Hamish D Toop, Clara Redondo, et al.
Oncotarget|June 4, 2016
BET inhibition as a new strategy for the treatment of gastric cancerRaquel C Montenegro, Peter G K Clark, Alison Howarth, et al.
Journal of Medicinal Chemistry|March 24, 2015
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2BPeiling Chen, Apirat Chaikuad, Paul Bamborough, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
ACS Chemical Biology|March 22, 2016
Structure of the Human Protein Kinase ZAK in Complex with VemurafenibSebastian Mathea, Kamal R Abdul Azeez, Eidarus Salah, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2015
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responsesAriane Hammitzsch, Cynthia Tallant, Oleg Fedorov, et al.
Nature Chemical Biology|May 10, 2016
Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talkSara Sdelci, Charles-Hugues Lardeau, Cynthia Tallant, et al.
Journal of Medicinal Chemistry|July 18, 2017
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of ProteinsNiall Igoe, Elliott D Bayle, Cynthia Tallant, et al.
Angewandte Chemie (International Ed. in English)|April 14, 2015
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorPeter G K Clark, Lucas C C Vieira, Cynthia Tallant, et al.
Journal of Medicinal Chemistry|January 10, 2017
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo StudiesNiall Igoe, Elliott D Bayle, Oleg Fedorov, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|June 28, 2016
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorPeter G K Clark, Lucas C C Vieira, Cynthia Tallant, et al.
ACS Chemical Biology|January 31, 2017
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye DiseaseJennifer Batson, Hamish D Toop, Clara Redondo, et al.
Oncotarget|June 4, 2016
BET inhibition as a new strategy for the treatment of gastric cancerRaquel C Montenegro, Peter G K Clark, Alison Howarth, et al.
Journal of Medicinal Chemistry|March 24, 2015
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2BPeiling Chen, Apirat Chaikuad, Paul Bamborough, et al.
Pageof 4